Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)

  • Technology appraisal
  • TA334
  • Published: 

History

Colorectal cancer (metastatic) - regorafenib: provisional matrix (pre-referral)

Colorectal cancer (metastatic) - regorafenib: final scope

Colorectal cancer (metastatic) - regorafenib: final matrix

Colorectal cancer (metastatic) - regorafenib: response to consultee and commentator comments on the draft scope and provisional matrix (post-referral)

Colorectal cancer (metastatic) - regorafenib: draft scope (pre-referral)

Colorectal cancer (metastatic) - regorafenib: equality impact assessment - scoping